Atlas Trials

A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia

Clinical trial NCT05757310 · RECRUITING

Trial details

NCT number
NCT05757310
Sponsor
City of Hope Medical Center
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Severe Aplastic AnemiaRefractory Severe Aplastic Anemia
Start date
2024-11-15
Primary completion
2027-06-18
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.